Article

Enhanced Expression of ABCB1 and Nrf2 in CD133-Positive Cancer Stem Cells Associates with…

Stem Cells International · 2020 · Shinji Goto, author Tsuyoshi Kawabata, author Tao-Sheng Li, author Andrea Ballini, Academic Editor

Key facts

Title Enhanced Expression of ABCB1 and Nrf2 in CD133-Positive Cancer Stem Cells Associates with Doxorubicin Resistance
First author Shinji Goto, author Tsuyoshi Kawabata, author Tao-Sheng Li, author Andrea Ballini, Academic Editor
Journal Stem Cells International
Published May 27, 2020
DOI 10.1155/2020/8868849
Devices mentioned K001005, K030065, K030320, K042550, K100464, K871763, K954145, K960874, K963847, K973350, K982271, K990827
Product codes mentioned DAE, JIQ, JIS, JIT, JIX, JJX, JLH, LBR, MVU, NSF, OAU, OUE and 3 more

At a glance

  • 10–99 FDA submissions mentioned
  • 10–99 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature